FURIN regulates cytotoxic T‐lymphocyte effector function and memory cell transition in mice
暂无分享,去创建一个
M. Nykter | J. Kesseli | T. Järvinen | Z. Ortutay | M. Pesu | C. Biron | M. Ploquin | I. Junttila | Markus J T Ojanen | Maria Vähätupa | S. Aittomäki | Juuso Määttä | Meeri Pekkarinen | Fernanda Munoz Caro | John J O 'shea
[1] Amit A. Patel,et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) , 2021, European journal of immunology.
[2] Z. Ortutay,et al. Identification of Novel Genetic Regulatory Region for Proprotein Convertase FURIN and Interferon Gamma in T Cells , 2021, Frontiers in Immunology.
[3] Vineet D. Menachery,et al. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis , 2021, Nature.
[4] B. Monk,et al. Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial. , 2020, The Lancet. Oncology.
[5] W. Xu,et al. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin , 2020, Signal Transduction and Targeted Therapy.
[6] Pei-Jer Chen,et al. Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects , 2020, Cell Reports.
[7] J. Creemers,et al. Loss of the proprotein convertase Furin in T cells represses mammary tumorigenesis in oncogene-driven triple negative breast cancer. , 2020, Cancer letters.
[8] A. Khatib,et al. Proprotein convertases: Key players in inflammation-related malignancies and metastasis , 2019, Cancer Letters.
[9] I. Soubeyran,et al. Inactivation of proprotein convertases in T cells inhibits PD-1 expression and creates a favorable immune microenvironment in colorectal cancer. , 2019, Cancer research.
[10] D. Sauter,et al. Furin‐mediated protein processing in infectious diseases and cancer , 2019, Clinical & translational immunology.
[11] E. Tartour,et al. Editorial: Tissue Resident Memory T Cells , 2019, Front. Immunol..
[12] O. Silvennoinen,et al. Increased expression of the proprotein convertase enzyme FURIN in rheumatoid arthritis , 2018, Scandinavian journal of rheumatology.
[13] M. Najafi,et al. CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review , 2018, Journal of cellular physiology.
[14] F. Mami-Chouaib,et al. The Emerging Role of CD8+ Tissue Resident Memory T (TRM) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin , 2018, Front. Immunol..
[15] O. Silvennoinen,et al. Proprotein convertase enzyme FURIN is upregulated in primary Sjögren's syndrome. , 2018, Clinical and experimental rheumatology.
[16] M. Rämet,et al. Proprotein convertase Furin1 expression in the Drosophila fat body is essential for a normal antimicrobial peptide response and bacterial host defense , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] Reinhold Förster,et al. Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo. , 2017, Trends in immunology.
[18] I. Frazer,et al. Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity , 2017, Cell Death & Disease.
[19] T. Järvinen,et al. T-cell-expressed proprotein convertase FURIN inhibits DMBA/TPA-induced skin cancer development , 2016, Oncoimmunology.
[20] M. Nykter,et al. Myeloid cell expressed proprotein convertase FURIN attenuates inflammation , 2016, Oncotarget.
[21] Nu Zhang,et al. Transforming growth factor-β signaling is constantly shaping memory T-cell population , 2015, Proceedings of the National Academy of Sciences.
[22] C. Ortutay,et al. Proprotein convertase FURIN regulates T cell receptor‐induced transactivation , 2015, Journal of leukocyte biology.
[23] N. Senzer,et al. Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.
[24] William Ritchie,et al. Real-time tracking of cell cycle progression during CD8+ effector and memory T-cell differentiation , 2015, Nature Communications.
[25] G. Corthals,et al. Proprotein Convertase FURIN Constrains Th2 Differentiation and Is Critical for Host Resistance against Toxoplasma gondii , 2014, The Journal of Immunology.
[26] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[27] D. Bluteau,et al. Smad and NFAT Pathways Cooperate To Induce CD103 Expression in Human CD8 T Lymphocytes , 2014, The Journal of Immunology.
[28] Z. Ortutay,et al. Genetics of the First Seven Proprotein Convertase Enzymes in Health and Disease , 2013, Current genomics.
[29] J. Schlom,et al. Inhibition of TGF-β1 Signaling Promotes Central Memory T Cell Differentiation , 2013, The Journal of Immunology.
[30] M. Huber,et al. The transcription factor Interferon Regulatory Factor 4 is required for the generation of protective effector CD8+ T cells , 2013, Proceedings of the National Academy of Sciences.
[31] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[32] Susan M. Kaech,et al. Transcriptional control of effector and memory CD8+ T cell differentiation , 2012, Nature Reviews Immunology.
[33] Annik Prat,et al. The biology and therapeutic targeting of the proprotein convertases , 2012, Nature Reviews Drug Discovery.
[34] D. Rao,et al. Phase I Trial of "bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell" Vaccine (FANG) in Advanced Cancer. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[35] S. Brunak,et al. A Systematic Study of Site-specific GalNAc-type O-Glycosylation Modulating Proprotein Convertase Processing* , 2011, The Journal of Biological Chemistry.
[36] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[37] E. Birney,et al. Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt , 2009, Nature Protocols.
[38] Chunxia Chen,et al. Foxp3 Processing by Proprotein Convertases and Control of Regulatory T Cell Function* , 2009, Journal of Biological Chemistry.
[39] Israel Steinfeld,et al. BMC Bioinformatics BioMed Central , 2008 .
[40] Y. Belkaid,et al. T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance , 2008, Nature.
[41] Douglas C. Wilson,et al. IL-12 Signaling Drives CD8+ T Cell IFN-γ Production and Differentiation of KLRG1+ Effector Subpopulations during Toxoplasma gondii Infection1 , 2008, The Journal of Immunology.
[42] J. O’Shea,et al. Proprotein convertase furin is preferentially expressed in T helper 1 cells and regulates interferon gamma. , 2006, Blood.
[43] A. Lauwers,et al. Limited Redundancy of the Proprotein Convertase Furin in Mouse Liver* , 2004, Journal of Biological Chemistry.
[44] R. Lahesmaa,et al. Early Target Genes of IL-12 and STAT4 Signaling in Th Cells1 , 2004, The Journal of Immunology.
[45] S. Szabo,et al. Antigen-driven effector CD8 T cell function regulated by T-bet , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[46] N. Miyasaka,et al. SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor beta2 subunit. , 2003, Biochemical and biophysical research communications.
[47] G. Thomas,et al. Furin at the cutting edge: From protein traffic to embryogenesis and disease , 2002, Nature Reviews Molecular Cell Biology.
[48] Laurie H Glimcher,et al. A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment , 2000, Cell.
[49] R. Ahmed,et al. CD4+ and CD8+ T cell interactions in IFN-gamma and IL-4 responses to viral infections: requirements for IL-2. , 1998, Journal of immunology.
[50] M. Bevan,et al. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. , 1998, Immunity.
[51] J. Orange,et al. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids , 1995, The Journal of experimental medicine.
[52] J. Orange,et al. Effects of IL-12 on the response and susceptibility to experimental viral infections. , 1994, Journal of immunology.
[53] J. Thorner,et al. Intracellular targeting and structural conservation of a prohormone-processing endoprotease. , 1989, Science.
[54] Sven Rahmann,et al. Genome analysis , 2022 .
[55] Nikolaj Blom,et al. Prediction of proprotein convertase cleavage sites. , 2004, Protein engineering, design & selection : PEDS.
[56] N. Seidah,et al. Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme. , 2001, The American journal of pathology.
[57] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .